NR2C2
Nuclear receptor subfamily 2 group C member 2
Also known as: hTAK1, NR2C2_HUMAN, TAK1, TR2R1, TR4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P49116
- Gene
- NR2C2
- Ensembl
- ENSG00000177463
- Chromosome
- 3
- Canonical length
- 596 aa
- Protein class
- Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein that belongs to the nuclear hormone receptor family. Members of this family act as ligand-activated transcription factors and function in many biological processes such as development, cellular differentiation and homeostasis. The activated receptor/ligand complex is translocated to the nucleus where it binds to hormone response elements of target genes. The protein encoded by this gene plays a role in protecting cells from oxidative stress and damage induced by ionizing radiation. The lack of a similar gene in mouse results in growth retardation, severe spinal curvature, subfertility, premature aging, and prostatic intraepithelial neoplasia (PIN) development. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2014]
Canonical amino-acid sequenceUniProt
596 residues, UniProt reviewed canonical sequence.
>P49116|NR2C2
1 MTSPSPRIQI ISTDSAVASP QRIQIVTDQQ TGQKIQIVTA VDASGSPKQQ FILTSPDGAG
61 TGKVILASPE TSSAKQLIFT TSDNLVPGRI QIVTDSASVE RLLGKTDVQR PQVVEYCVVC
121 GDKASGRHYG AVSCEGCKGF FKRSVRKNLT YSCRSNQDCI INKHHRNRCQ FCRLKKCLEM
181 GMKMESVQSE RKPFDVQREK PSNCAASTEK IYIRKDLRSP LIATPTFVAD KDGARQTGLL
241 DPGMLVNIQQ PLIREDGTVL LATDSKAETS QGALGTLANV VTSLANLSES LNNGDTSEIQ
301 PEDQSASEIT RAFDTLAKAL NTTDSSSSPS LADGIDTSGG GSIHVISRDQ STPIIEVEGP
361 LLSDTHVTFK LTMPSPMPEY LNVHYICESA SRLLFLSMHW ARSIPAFQAL GQDCNTSLVR
421 ACWNELFTLG LAQCAQVMSL STILAAIVNH LQNSIQEDKL SGDRIKQVME HIWKLQEFCN
481 SMAKLDIDGY EYAYLKAIVL FSPDHPGLTS TSQIEKFQEK AQMELQDYVQ KTYSEDTYRL
541 ARILVRLPAL RLMSSNITEE LFFTGLIGNV SIDSIIPYIL KMETAEYNGQ ITGASLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NR2C2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 22 nTPM
- cerebellum: 22 nTPM
- thymus: 18 nTPM
- testis: 18 nTPM
- pituitary gland: 18 nTPM
- small intestine: 17 nTPM
Single-cell type
- cardiomyocytes: 655 nCPM
- neutrophils: 259 nCPM
- epicardial cells: 250 nCPM
- neutrophil progenitors: 193 nCPM
- somatotrophs: 173 nCPM
- myonuclei: 154 nCPM
Immune cell
- basophil: 1.8 nTPM
- gdT-cell: 0.9 nTPM
- naive B-cell: 0.9 nTPM
- neutrophil: 0.9 nTPM
- MAIT T-cell: 0.8 nTPM
- plasmacytoid DC: 0.8 nTPM
Brain region
- cerebellum: 78 nTPM
- cerebral cortex: 67 nTPM
- white matter: 66 nTPM
- amygdala: 66 nTPM
- thalamus: 66 nTPM
- hypothalamus: 65 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.18
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- negative regulation of transcription by RNA polymerase II
- nervous system development
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of embryonic development
- positive regulation of JNK cascade
- positive regulation of transcription by RNA polymerase II
- regulation of DNA-templated transcription
- spermatogenesis
- tumor necrosis factor-mediated signaling pathway
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- nuclear receptor activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nuclear hormone receptor, ligand-binding domain
- Zinc finger, nuclear hormone receptor-type
- Nuclear hormone receptor
- Zinc finger, NHR/GATA-type
- Nuclear hormone receptor-like domain superfamily
- Nuclear receptor subfamily 2 group C member 1/2-like, DNA-binding domain
- Nuclear receptor subfamily 2 group C member 1/2-like, ligand binding domain
- Nuclear hormone receptor family NR2 subfamily
- Ligand-binding domain of nuclear hormone receptor
- Double treble clef zinc finger, C4 type
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NR2C2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NR2C2 as an antibody target. Whether an autoantibody or antibody against NR2C2 could matter depends on whether native NR2C2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NR2C2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NR2C2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...